4//SEC Filing
Ropp Sam 4
Accession 0001209191-23-046275
CIK 0001850906other
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 4:31 PM ET
Size
8.0 KB
Accession
0001209191-23-046275
Insider Transaction Report
Form 4
Ropp Sam
Chief Commercial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2023-08-15+100,000→ 100,000 totalExercise: $0.54Exp: 2033-08-14→ Common Stock (100,000 underlying) - Award
Employee Stock Option (right to buy)
2023-08-15+100,000→ 100,000 totalExercise: $0.54Exp: 2033-08-14→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]The option shares vest and become exercisable in 48 equal monthly installments measured from August 15, 2023, subject to the Reporting Person's continuous service with the Issuer.
- [F2]Subject to the achievement of certain performance targets by December 31, 2023, the Reporting Person may earn up to 100,000 stock options pursuant to this award. Any stock options earned will vest 25% on August 15, 2024, and the remaining option shares will vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer.
Documents
Issuer
Singular Genomics Systems, Inc.
CIK 0001850906
Entity typeother
Related Parties
1- filerCIK 0001973313
Filing Metadata
- Form type
- 4
- Filed
- Aug 16, 8:00 PM ET
- Accepted
- Aug 17, 4:31 PM ET
- Size
- 8.0 KB